Nicola Lorusso

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Effectiveness of high-dose versus standard-dose influenza vaccines against severe respiratory and secondary cardiovascular outcomes in adults aged ≥80 years.

Effectiveness of high-dose versus standard-dose influenza vaccines against severe respiratory and secondary cardiovascular outcomes in adults aged ≥80 years.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: February 13, 2026

Young adults at risk of emerging serotype 4 invasive pneumococcal disease vs. other serotypes in Andalusia (Spain), 2022 to 2024: optimising conjugated vaccines strategies.

Young adults at risk of emerging serotype 4 invasive pneumococcal disease vs. other serotypes in Andalusia (Spain), 2022 to 2024: optimising conjugated vaccines strategies.

Journal: Vaccine

Published: February 01, 2026

Monitoring effectiveness of nirsevimab immunization against RSV hospitalization using surveillance data: a test-negative case-control study, Spain, October 2024-March 2025.

Monitoring effectiveness of nirsevimab immunization against RSV hospitalization using surveillance data: a test-negative case-control study, Spain, October 2024-March 2025.

Journal: Epidemiology and infection

Published: December 09, 2025

Nirsevimab and Hospitalization for Lower Respiratory Tract Infection During the Second Season.

Nirsevimab and Hospitalization for Lower Respiratory Tract Infection During the Second Season.

Journal: Pediatrics

Published: December 09, 2025

Cocirculation of endemic and recently introduced West Nile Virus lineage 1 clades in Southern Spain.

Cocirculation of endemic and recently introduced West Nile Virus lineage 1 clades in Southern Spain.

Journal: One health (Amsterdam, Netherlands)

Published: September 02, 2025

First autochthonous transmission of West Nile virus (WNV) lineage 2 to humans in Spain.

First autochthonous transmission of West Nile virus (WNV) lineage 2 to humans in Spain.

Journal: One health (Amsterdam, Netherlands)

Published: March 05, 2025

A Genomic Surveillance Circuit for Emerging Viral Pathogens.

A Genomic Surveillance Circuit for Emerging Viral Pathogens.

Journal: Microorganisms

Published: March 04, 2025

Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023/24 season.

Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023/24 season.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 07, 2025

Carbapenemase production and in-hospital mortality associated with multidrug-resistant bacteria: a retrospective study conducted in Granada, Spain.

Carbapenemase production and in-hospital mortality associated with multidrug-resistant bacteria: a retrospective study conducted in Granada, Spain.

Journal: Infectious diseases (London, England)

Published: January 28, 2025

Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023-2024 Season in Andalusia, Spain (NIRSEGRAND).

Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023-2024 Season in Andalusia, Spain (NIRSEGRAND).

Journal: Vaccines

Published: January 05, 2025

Increased trends in reported sexually transmitted infections according to age groups and sex in Spain, 2016-2022.

Increased trends in reported sexually transmitted infections according to age groups and sex in Spain, 2016-2022.

Journal: Infectious diseases (London, England)

Published: November 05, 2024

Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24.

Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: October 04, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026